1,770
Views
26
CrossRef citations to date
0
Altmetric
Review

HIV-1 vaccines

Challenges and new perspectives

, &
Pages 1734-1746 | Received 15 Jan 2014, Accepted 07 Mar 2014, Published online: 17 Mar 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Hamza Loucif, Xavier Dagenais-Lussier, Cherifa Beji, Léna Cassin, Hani Jrade, Roman Tellitchenko, Jean-Pierre Routy, David Olagnier & Julien van Grevenynghe. (2021) Lipophagy confers a key metabolic advantage that ensures protective CD8A T-cell responses against HIV-1. Autophagy 17:11, pages 3408-3423.
Read now
Jean-Louis Excler & Jerome H. Kim. (2019) Novel prime-boost vaccine strategies against HIV-1. Expert Review of Vaccines 18:8, pages 765-779.
Read now
Lynette Siv Chea & Rama Rao Amara. (2017) Immunogenicity and efficacy of DNA/MVA HIV vaccines in rhesus macaque models. Expert Review of Vaccines 16:10, pages 973-985.
Read now
Sunil K Khattar, Senthilkumar Palaniyandi, Sweety Samal, Celia C LaBranche, David C Montefiori, Xiaoping Zhu & Siba K Samal. (2015) Evaluation of humoral, mucosal, and cellular immune responses following co-immunization of HIV-1 Gag and Env proteins expressed by Newcastle disease virus. Human Vaccines & Immunotherapeutics 11:2, pages 504-515.
Read now

Articles from other publishers (22)

Hiroshi Ishii, Kazutaka Terahara, Takushi Nomura, Midori Okazaki, Hiroyuki Yamamoto, Tsugumine Shu, Hiromi Sakawaki, Tomoyuki Miura, David I. Watkins & Tetsuro Matano. (2022) Env-independent protection of intrarectal SIV challenge by vaccine induction of Gag/Vif-specific CD8+ T cells but not CD4+ T cells. Molecular Therapy 30:5, pages 2048-2057.
Crossref
Mahmoud Mohammad Yaseen, Nizar Mohammad Abuharfeil & Homa Darmani. (2021) The impact of MDSCs on the efficacy of preventive and therapeutic HIV vaccines. Cellular Immunology 369, pages 104440.
Crossref
Qian Wang & Linqi Zhang. (2019) Broadly neutralizing antibodies and vaccine design against HIV-1 infection. Frontiers of Medicine 14:1, pages 30-42.
Crossref
Qiang Chen, Matthew Dent & Hugh Mason. 2018. Molecular Pharming. Molecular Pharming 231 273 .
Kristina Ortiz, Rebecca S. Sampathkumar, Aftab A. Ansari & Siddappa N. Byrareddy. (2017) Preliminary studies on the use of pertussis toxin for the modulation of intravaginal SIV transmission in rhesus macaques. Journal of Medical Primatology 46:6, pages 327-331.
Crossref
A. Volz & G. Sutter. 2017. 187 243 .
C.L. Parks. 2017. Human Vaccines. Human Vaccines 25 63 .
Jean-Louis Excler & Nelson L. Michael. (2016) Lessons from HIV-1 vaccine efficacy trials. Current Opinion in HIV and AIDS 11:6, pages 607-613.
Crossref
Uddhav Timilsina & Ritu Gaur. (2016) Modulation of apoptosis and viral latency – an axis to be well understood for successful cure of human immunodeficiency virus. Journal of General Virology 97:4, pages 813-824.
Crossref
Chongbo Zhao, Zhujun Ao & Xiaojian Yao. (2016) Current Advances in Virus-Like Particles as a Vaccination Approach against HIV Infection. Vaccines 4:1, pages 2.
Crossref
Ali H. Ellebedy & Rafi Ahmed. 2016. The Vaccine Book. The Vaccine Book 283 310 .
Jean-Louis Excler, Merlin L. Robb & Jerome H. Kim. (2015) Prospects for a Globally Effective HIV-1 Vaccine. American Journal of Preventive Medicine 49:6, pages S307-S318.
Crossref
Nittaya PhanuphakYing-Ru LoYiming ShaoSunil Suhas SolomonRobert J. O'ConnellSodsai TovanabutraDavid ChangJerome H. KimJean Louis Excler. (2015) HIV Epidemic in Asia: Implications for HIV Vaccine and Other Prevention Trials. AIDS Research and Human Retroviruses 31:11, pages 1060-1076.
Crossref
Jean-Louis Excler, Merlin L. Robb & Jerome H. Kim. (2015) Prospects for a globally effective HIV-1 vaccine. Vaccine 33, pages D4-D12.
Crossref
Ying-Ru LoCarissa ChuJintanat AnanworanichJean-Louis ExclerJoseph D. Tucker. (2015) Stakeholder Engagement in HIV Cure Research: Lessons Learned from Other HIV Interventions and the Way Forward. AIDS Patient Care and STDs 29:7, pages 389-399.
Crossref
Zhi-Ying Chen, Fei Ma, Hailiang Huang & Cheng-Yi He. (2015) Synthetic immunity to break down the bottleneck of cancer immunotherapy. Science Bulletin 60:11, pages 977-985.
Crossref
Joseph R. Francica, Zizhang Sheng, Zhenhai Zhang, Yoshiaki Nishimura, Masashi Shingai, Akshaya Ramesh, Brandon F. Keele, Stephen D. Schmidt, Barbara J. Flynn, Sam Darko, Rebecca M. Lynch, Takuya Yamamoto, Rodrigo Matus-Nicodemos, David Wolinsky, Betty Barnabas, Robert Blakesley, Gerry Bouffard, Shelise Brooks, Holly Coleman, Mila Dekhtyar, Michael Gregory, Xiaobin Guan, Jyoti Gupta, Joel Han, Shi-ling Ho, Richelle Legaspi, Quino Maduro, Cathy Masiello, Baishali Maskeri, Jenny McDowell, Casandra Montemayor, James Mullikin, Morgan Park, Nancy Riebow, Karen Schandler, Brian Schmidt, Christina Sison, Mal Stantripop, James Thomas, Pamela Thomas, Meg Vemulapalli, Alice Young, Martha Nason, Nicholas M. Valiante, Padma Malyala, Ennio De Gregorio, Susan W. Barnett, Manmohan Singh, Derek T. O’Hagan, Richard A. Koup, John R. Mascola, Malcolm A. Martin, Thomas B. Kepler, Daniel C. Douek, Lawrence Shapiro & Robert A. Seder. (2015) Analysis of immunoglobulin transcripts and hypermutation following SHIVAD8 infection and protein-plus-adjuvant immunization. Nature Communications 6:1.
Crossref
Yegor Voronin, Helene Zinszner, Carissa Karg, Katie Brooks, Robert Coombs, John Hural, Renee Holt, Pat Fast, Mary Allen, Mary Allen, Michael Busch, Pat Fast, Ulrich Fruth, Hana Golding, Surender Khurana, Joseph Mulenga, Sheila Peel, Marco Schito, Yegor Voronin, Nomampondo Barnabas, Christopher Bentsen, Barney Graham, Glenda Gray, Andrew Levin, Margaret McCluskey, Robert O’Connell, Bill Snow & Mark Ware. (2015) HIV vaccine-induced sero-reactivity: A challenge for trial participants, researchers, and physicians. Vaccine 33:10, pages 1243-1249.
Crossref
Lucía Orellana-Escobedo, Sergio Rosales-Mendoza, Andrea Romero-Maldonado, Juliana Parsons, Eva L. Decker, Elizabeth Monreal-Escalante, Leticia Moreno-Fierros & Ralf Reski. (2014) An Env-derived multi-epitope HIV chimeric protein produced in the moss Physcomitrella patens is immunogenic in mice. Plant Cell Reports 34:3, pages 425-433.
Crossref
Maria L. Knudsen, Karl Ljungberg, Roger Tatoud, Jonathan Weber, Mariano Esteban & Peter Liljeström. (2015) Alphavirus Replicon DNA Expressing HIV Antigens Is an Excellent Prime for Boosting with Recombinant Modified Vaccinia Ankara (MVA) or with HIV gp140 Protein Antigen. PLOS ONE 10:2, pages e0117042.
Crossref
Edward P Rybicki. (2014) Plant-based vaccines against viruses. Virology Journal 11:1.
Crossref
Milena Veselinovic, Kuo-Hsiung Yang, Jonathan LeCureux, Craig Sykes, Leila Remling-Mulder, Angela D.M. Kashuba & Ramesh Akkina. (2014) HIV pre-exposure prophylaxis: Mucosal tissue drug distribution of RT inhibitor Tenofovir and entry inhibitor Maraviroc in a humanized mouse model. Virology 464-465, pages 253-263.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.